Prestige Consumer Healthcare (PBH) Treasury Shares (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Treasury Shares came in at $438.5 million in Q4 2025, up 64.96% year-on-year from $265.8 million in Q4 2024, and up 11.81% quarter-over-quarter from $392.2 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Treasury Shares (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Treasury Shares history runs 15 years deep, the most recent figure standing at $438.5 million for Q4 2025.
- On a quarterly basis, Treasury Shares rose 64.96% year-over-year to $438.5 million in Q4 2025; TTM through Dec 2025 was $438.5 million, a 64.96% increase from a year earlier, with the FY2025 full-year figure at $277.2 million, up 26.22% from the prior year.
- Treasury Shares rose to $438.5 million in Q4 2025 per PBH's latest filing, from $392.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $8.9 million in Q4 2025 and bottomed at $4.1 million in Q1 2021.
- The 5-year median for Treasury Shares is $5.7 million (2023), against an average of $5.7 million.
- Across the five-year window, Treasury Shares gained 2.23% in 2022 and surged 64.96% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $133.6 million in 2021, then jumped by 41.5% to $189.1 million in 2022, then grew by 16.14% to $219.6 million in 2023, then grew by 21.04% to $265.8 million in 2024, then jumped by 64.96% to $438.5 million in 2025.
- Per Business Quant, the three latest PBH Treasury Shares figures stand at $438.5 million (Q4 2025), $392.2 million (Q3 2025), and $316.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 8.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.88 Mn |
| Dec 31, 2025 | 8.88 Mn |
| Dec 31, 2025 | 438.55 Mn |
| Dec 31, 2025 | 438.55 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Sep 30, 2025 | 392.23 Mn |
| Sep 30, 2025 | 8.11 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Jun 30, 2025 | 316.33 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Mar 31, 2025 | 277.21 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Dec 31, 2024 | 265.84 Mn |
| Dec 31, 2024 | 265.84 Mn |
| Dec 31, 2024 | 6.36 Mn |